How should anti-hypertensive medications be adjusted before screening for primary aldosteronism?

How should anti-hypertensive medications be adjusted before screening for primary aldosteronism?

Anti-hypertensive medications may affect plasma renin activity and/or plasma aldosterone concentration, misleading the interpretation of the aldosterone-to-renin ratio when screening for primary aldosteronism. The Task Force of Taiwan PA recommends that, when necessary, using α-adrenergic receptor b...

Full description

Bibliographic Details
Main Authors: Jin-Ying Lu, Yi-Yao Chang, Ting-Wei Lee, Ming-Hsien Wu, Zheng-Wei Chen, Yen-Ta Huang, Tai-Shuan Lai, Leay Kiaw Er, Yen-Hung Lin, Vin-Cent Wu, Hao-Min Cheng, Hsien-Li Kao, Charles Jia-Yin Hou, Kwan-Dun Wu, Szu-Tah Chen, Feng-Hsuan Liu
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Journal of the Formosan Medical Association
Subjects:
Primary aldosteronism
Aldosterone-to-renin ratio
Anti-hypertensive medications
α-adrenergic receptor blocking agents
Centrally acting α-adrenergic agonists
Nondihydropyridine calcium channel blockers
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664623001900

Internet

http://www.sciencedirect.com/science/article/pii/S0929664623001900

Similar Items